These side effects ended up notably milder in comparison to an inhibitor of both bromodomains. An in depth molecular Investigation also disclosed that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes.  ― Stephen Taylor There may be greater treatment burden for individuals In this particular trial compared to https://trevorkwhrc.madmouseblog.com/12398353/brd4-targeted-therapy-abbv-744-clinical-data-no-further-a-mystery